The Global Fish Vaccine Market Growth Accelerated By Rising Global Demand For Prevention Of Fish Diseases



Fish vaccines are biological preparations used to prevent infectious diseases affecting fish such as viruses, bacteria and parasites. They help protect farmed fish and shrimp populations from mortalities and economic losses caused by infectious diseases.

The global fish vaccine market is estimated to be valued at US$ 265.4 Mn in 2023 and is expected to exhibit a CAGR of 5.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends: The rising global demand for prevention of fish diseases is one of the key trends driving the growth of the fish vaccine market. Fish farming is becoming increasingly important to meet the rising demand for seafood. However, intensive aquaculture also increases the risk of disease outbreaks which can lead to huge economic losses if not prevented or controlled. Vaccines help promote sustainable aquaculture practices by protecting fish from infectious diseases. This reduces treatment and mortality costs and guarantees food safety. Hence, farmers are increasingly adopting vaccination to minimize the impact of diseases on fish production.


Segment Analysis
The global fish vaccine market is dominated by the ornamental segment. Ornamental fish farming is a booming industry and contributes significantly to the market revenues. Ornamental fish are at high risk of contracting infectious diseases owing to high density farming practices. Vaccines help curb the spread of diseases and are extensively used in ornamental fish farms.

Key Takeaways
The Global Fish Vaccine Market Size  is expected to witness high growth over the forecast period of 2023 to 2030. The market size is projected to reach US$ 265.4 Mn by 2023 from US$ 200 Mn in 2020, registering a CAGR of 5.7% during 2023-2030.

Regional analysis
The Asia Pacific region currently dominates the global fish vaccine market and is expected to continue its dominance through the forecast period. extensive fish farming in countries like China, India, Vietnam contributes to the large market size of the region. High risk of infectious disease outbreaks due to intensive fish farming practices drives the adoption of vaccines.

Key players
Key players operating in the fish vaccine market are Bayer AG, BASF SE, Syngenta AG, DuPont de Nemours Inc., ADAMA Ltd., Arysta LifeScience, Nufarm, Nissan Chemical Industries Ltd., Shandong Binnong Tech Co Ltd., FMC Corporation, Monsanto Company, UPL, Bhaskar Agrochemicals Ltd., Dhanuka Agritech Limited, and Insecticides (India) Ltd. Companies are focusing on developing novel vaccines for newly emerging diseases.

Get more insights on this topic:

Comments

Post a Comment

Popular posts from this blog

Eyewear Market Is Estimated To Witness High Growth Owing To the Growing Demand for Prescription Eyewear

Image
  Eyewear Market The global Eyewear Market is estimated to be valued at US$ 273.4 billion in 2018 and is expected to exhibit a CAGR of 6.0% over the forecast period 2023-2030 , as highlighted in a new report published by Coherent Market Insights. Market Overview: The Eyewear Market includes products such as prescription glasses, contact lenses, and sunglasses. These products offer vision correction and protection from harmful ultraviolet (UV) rays. The increasing prevalence of eye disorders and the growing awareness about the importance of eye health are driving the demand for eyewear products. Furthermore, the rising use of digital devices and exposure to blue light is also contributing to the need for prescription eyewear to reduce eye strain and prevent vision problems. Market Key Trends: One key trend in the Eyewear Market is the increasing demand for fashionable and luxury eyewear. Consumers are not only seeking vision correction but also looking for eyewear that complements
Read more

The Mobile Computed Tomography Is The Fastest Growing Segment Fueling The Growth Of Computed Tomography Market

Image
  Computed Tomography Market The global Computed Tomography Market is estimated to be valued at US$ 7.9 Bn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030 , as highlighted in a new report published by Coherent Market Insights. Market Overview : Computed tomography, commonly known as CT or CAT scan, is a medical imaging technique used for clinical diagnosis and interventional procedures. CT imaging provides cross-sectional views of the internal organs to accurately detect medical conditions such as cancer, blood clots, lung nodules, or bone fractures. CT scans generate three-dimensional images or slices of the bones, blood vessels, and soft tissues inside the body. Market key trends: One of the key trends in the computed tomography market is the growing adoption of mobile CT systems. Mobile CT systems are CT devices that can be transported to various locations within a hospital campus or healthcare facility. Mobile CT scanners provide versat
Read more

The Electronic Warfare Market Will Grow At Highest Pace Owing To Rising Adoption Of Advanced Electronic Warfare Systems In Defense Sector

Image
  Electronic Warfare Market The electronic warfare market involves technologies, processes and tactics to dominate, disrupt and deny the electromagnetic spectrum that supports mission-critical functions which include communications, command and control, sensors, targeting and surveillance. Effective electronic warfare systems play an important role in modern warfare by minimizing risks and maximizing operational effectiveness. They help to suppress enemy use of electromagnetic spectrum and keep friendly spectrum available for own use. Some key functions of electronic warfare systems include electronic attack, electronic protection and electronic support. The growing use of technologically advanced aircraft, ships and weapons systems has increased the demand for sophisticated electronic warfare capabilities to counter emerging electromagnetic threats and stay ahead in the battlefield. The Global Electronic Warfare Market is estimated to be valued at US$ 18.45 Bn in 2024 and is expected
Read more